ALGS
Price
$6.03
Change
-$0.42 (-6.51%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
36.8M
Intraday BUY SELL Signals
XNCR
Price
$13.99
Change
-$0.40 (-2.78%)
Updated
Nov 13 closing price
Capitalization
999.75M
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGS vs XNCR

Header iconALGS vs XNCR Comparison
Open Charts ALGS vs XNCRBanner chart's image
Aligos Therapeutics
Price$6.03
Change-$0.42 (-6.51%)
Volume$358
Capitalization36.8M
Xencor
Price$13.99
Change-$0.40 (-2.78%)
Volume$662.73K
Capitalization999.75M
ALGS vs XNCR Comparison Chart in %
View a ticker or compare two or three
VS
ALGS vs. XNCR commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a StrongBuy and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ALGS: $6.07 vs. XNCR: $13.99)
Brand notoriety: ALGS and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 89% vs. XNCR: 51%
Market capitalization -- ALGS: $36.8M vs. XNCR: $999.75M
ALGS [@Biotechnology] is valued at $36.8M. XNCR’s [@Biotechnology] market capitalization is $999.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • ALGS’s TA Score: 4 bullish, 6 bearish.
  • XNCR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than XNCR.

Price Growth

ALGS (@Biotechnology) experienced а -14.51% price change this week, while XNCR (@Biotechnology) price change was -0.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

XNCR is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($1B) has a higher market cap than ALGS($36.8M). XNCR YTD gains are higher at: -37.380 vs. ALGS (-83.798). ALGS has higher annual earnings (EBITDA): -75.81M vs. XNCR (-125.38M). XNCR has more cash in the bank: 444M vs. ALGS (123M). ALGS has less debt than XNCR: ALGS (6.88M) vs XNCR (67.9M). XNCR has higher revenues than ALGS: XNCR (147M) vs ALGS (3.17M).
ALGSXNCRALGS / XNCR
Capitalization36.8M1B4%
EBITDA-75.81M-125.38M60%
Gain YTD-83.798-37.380224%
P/E RatioN/AN/A-
Revenue3.17M147M2%
Total Cash123M444M28%
Total Debt6.88M67.9M10%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGSXNCR
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 18 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signal:
Gain/Loss:
XNCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICFSX10.120.04
+0.40%
ICON Consumer Select Institutional
PASSX59.070.10
+0.17%
T. Rowe Price Small-Cap Stock Adv
RWCEX14.470.02
+0.14%
Redwheel Global Emerging Equity Ins
TEMUX17.89N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
FMSTX35.53N/A
N/A
Federated Hermes MDT Large Cap Value IS

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with ARWR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-3.37%
ARWR - ALGS
42%
Loosely correlated
-0.19%
BEAM - ALGS
41%
Loosely correlated
-2.71%
RXRX - ALGS
40%
Loosely correlated
-1.27%
XNCR - ALGS
40%
Loosely correlated
-3.23%
DSGN - ALGS
40%
Loosely correlated
-1.93%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with NUVL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-3.23%
NUVL - XNCR
61%
Loosely correlated
+0.91%
CRNX - XNCR
59%
Loosely correlated
-0.28%
NRIX - XNCR
55%
Loosely correlated
-5.37%
IDYA - XNCR
55%
Loosely correlated
-0.19%
RCUS - XNCR
54%
Loosely correlated
-1.43%
More